TissueGen Showcases Groundbreaking ELUTE® Fiber for Implantable Drug Delivery at MD&M East

01 Jun TissueGen Showcases Groundbreaking ELUTE® Fiber for Implantable Drug Delivery at MD&M East

ELUTE® Fiber Ideal for Advanced Drug Delivery, Nerve Regeneration, and Tissue Engineering

WHO: TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and tissue engineering.

WHAT: At MD&M East, TissueGen will be exhibiting its ELUTE fiber in Booth 515. TissueGen’s patented, cutting-edge room temperature extrusion process enables loading of ELUTE fibers with the widest range possible of drugs and biologically-derived entities including temperature sensitive proteins, growth factors, enzymes, small molecule pharmaceuticals, and viruses. ELUTE fibers are available in pharmaceutical and growth factor formats ideal for a wide variety of medical and research applications including spinal cord injury repair, tissue engineering and nerve regeneration.

ELUTE fibers can directly replace standard fibers used in biodegradable textiles currently on the market and provide significantly improved clinical outcomes by adding therapeutic agents directly at the site of the implant. By delivering drugs at the site of implantation, ELUTE fibers enable medical devices to tailor the body’s response. Frequently, localized drug delivery is preferred over systemic delivery. Additionally, TissueGen’s drug loaded biodegradable fibers stay in place once implanted. Whereas drugs injected via millions of microspheres or billions of nanoparticles cannot be retrieved from the body, implantables with ELUTE fibers may be retrieved as required by the treating physician.

TissueGen works with leading medical device and medical textile partners to deliver fiber and textile platforms for use in drug-eluting medical device applications such as small diameter vascular grafts and stents, tissue and nerve regeneration, orthopedics, and sutures. TissueGen’s patented drug delivery technology is available today as ELUTE fiber.

WHERE:
MD&M East
Booth 515
Javits Convention Center
New York, NY

WHEN: MD&M West will take place from June 9-11, 2015.

 

To schedule a briefing, please contact Jordan Bouclin at Jordan.bouclin@svmpr.com or (401)490-9700.

 

About TissueGen

TissueGen® Inc. has more than four decades of cumulative experience in extruding biodegradable polymer fibers with broad drug delivery capabilities well-suited for advanced drug delivery, nerve regeneration, and tissue engineering. TissueGen offers the medical market a portfolio of issued patents on unique drug delivery technology with the capability to incorporate and elute a broad range of biologically derived therapeutics and standard pharmaceuticals in hydrophobic, biodegradable polymeric fibers or tubes for sustained therapeutic release. For more information, please visit www.tissuegen.com.

 

# # #

 

For more information contact:

Jordan Bouclin

SVM Public Relations

401-490-9700

jordan.bouclin@svmpr.com

No Comments

Sorry, the comment form is closed at this time.